(R)-(−)-Aloesaponol III 8-Methyl Ether from Eremurus persicus: A Novel Compound against Leishmaniosis

Detalhes bibliográficos
Autor(a) principal: Rossi, Daniela
Data de Publicação: 2017
Outros Autores: Ahmed, Karzan, Gaggeri, Raffaella, Della Volpe, Serena, Maggi, Lauretta, Mazzeo, Giuseppe, Longhi, Giovanna, Abbate, Sergio, Corana, Federica, Martino, Emanuela, Machado, Marisa, Varandas, Raquel, Sousa, Maria, Collina, Simona
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://hdl.handle.net/10316/38794
https://doi.org/10.3390/molecules22040519
Resumo: Leishmaniosis is a neglected tropical disease which affects several millions of people worldwide. The current drug therapies are expensive and often lack efficacy, mainly due to the development of parasite resistance. Hence, there is an urgent need for new drugs effective against Leishmania infections. As a part of our ongoing study on the phytochemical characterization and biological investigation of plants used in the traditional medicine of western and central Asia, in the present study, we focused on Eremurus persicus root extract in order to evaluate its potential in the treatment of leishmaniosis. As a result of our study, aloesaponol III 8-methyl ether (ASME) was isolated for the first time from Eremurus persicus root extract, its chemical structure elucidated by means of IR and NMR experiments and the (R) configuration assigned by optical activity measurements: chiroptical aspects were investigated with vibrational circular dichroism (VCD) and electronic circular dichroism (ECD) spectroscopies and DFT (density functional theory) quantum mechanical calculations. Concerning biological investigations, our results clearly proved that (R)-ASME inhibits Leishmania infantum promastigotes viability (IC50 73 µg/mL), inducing morphological alterations and mitochondrial potential deregulation. Moreover, it is not toxic on macrophages at the concentration tested, thus representing a promising molecule against Leishmania infections.
id RCAP_a73b1687bdf5d4a82e994fecc6cc64b7
oai_identifier_str oai:estudogeral.uc.pt:10316/38794
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling (R)-(−)-Aloesaponol III 8-Methyl Ether from Eremurus persicus: A Novel Compound against LeishmaniosisLeishmaniosisDrug identificationEremurus persicusPlant extract(R)-aloesaponol III-8 methyl etherLeishmaniosis is a neglected tropical disease which affects several millions of people worldwide. The current drug therapies are expensive and often lack efficacy, mainly due to the development of parasite resistance. Hence, there is an urgent need for new drugs effective against Leishmania infections. As a part of our ongoing study on the phytochemical characterization and biological investigation of plants used in the traditional medicine of western and central Asia, in the present study, we focused on Eremurus persicus root extract in order to evaluate its potential in the treatment of leishmaniosis. As a result of our study, aloesaponol III 8-methyl ether (ASME) was isolated for the first time from Eremurus persicus root extract, its chemical structure elucidated by means of IR and NMR experiments and the (R) configuration assigned by optical activity measurements: chiroptical aspects were investigated with vibrational circular dichroism (VCD) and electronic circular dichroism (ECD) spectroscopies and DFT (density functional theory) quantum mechanical calculations. Concerning biological investigations, our results clearly proved that (R)-ASME inhibits Leishmania infantum promastigotes viability (IC50 73 µg/mL), inducing morphological alterations and mitochondrial potential deregulation. Moreover, it is not toxic on macrophages at the concentration tested, thus representing a promising molecule against Leishmania infections.MDPI2017info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articlehttp://hdl.handle.net/10316/38794http://hdl.handle.net/10316/38794https://doi.org/10.3390/molecules22040519https://doi.org/10.3390/molecules22040519eng1420-3049http://www.mdpi.com/1420-3049/22/4/519Rossi, DanielaAhmed, KarzanGaggeri, RaffaellaDella Volpe, SerenaMaggi, LaurettaMazzeo, GiuseppeLonghi, GiovannaAbbate, SergioCorana, FedericaMartino, EmanuelaMachado, MarisaVarandas, RaquelSousa, MariaCollina, Simonainfo:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2022-07-28T16:14:27Zoai:estudogeral.uc.pt:10316/38794Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T20:47:29.138362Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv (R)-(−)-Aloesaponol III 8-Methyl Ether from Eremurus persicus: A Novel Compound against Leishmaniosis
title (R)-(−)-Aloesaponol III 8-Methyl Ether from Eremurus persicus: A Novel Compound against Leishmaniosis
spellingShingle (R)-(−)-Aloesaponol III 8-Methyl Ether from Eremurus persicus: A Novel Compound against Leishmaniosis
Rossi, Daniela
Leishmaniosis
Drug identification
Eremurus persicus
Plant extract
(R)-aloesaponol III-8 methyl ether
title_short (R)-(−)-Aloesaponol III 8-Methyl Ether from Eremurus persicus: A Novel Compound against Leishmaniosis
title_full (R)-(−)-Aloesaponol III 8-Methyl Ether from Eremurus persicus: A Novel Compound against Leishmaniosis
title_fullStr (R)-(−)-Aloesaponol III 8-Methyl Ether from Eremurus persicus: A Novel Compound against Leishmaniosis
title_full_unstemmed (R)-(−)-Aloesaponol III 8-Methyl Ether from Eremurus persicus: A Novel Compound against Leishmaniosis
title_sort (R)-(−)-Aloesaponol III 8-Methyl Ether from Eremurus persicus: A Novel Compound against Leishmaniosis
author Rossi, Daniela
author_facet Rossi, Daniela
Ahmed, Karzan
Gaggeri, Raffaella
Della Volpe, Serena
Maggi, Lauretta
Mazzeo, Giuseppe
Longhi, Giovanna
Abbate, Sergio
Corana, Federica
Martino, Emanuela
Machado, Marisa
Varandas, Raquel
Sousa, Maria
Collina, Simona
author_role author
author2 Ahmed, Karzan
Gaggeri, Raffaella
Della Volpe, Serena
Maggi, Lauretta
Mazzeo, Giuseppe
Longhi, Giovanna
Abbate, Sergio
Corana, Federica
Martino, Emanuela
Machado, Marisa
Varandas, Raquel
Sousa, Maria
Collina, Simona
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Rossi, Daniela
Ahmed, Karzan
Gaggeri, Raffaella
Della Volpe, Serena
Maggi, Lauretta
Mazzeo, Giuseppe
Longhi, Giovanna
Abbate, Sergio
Corana, Federica
Martino, Emanuela
Machado, Marisa
Varandas, Raquel
Sousa, Maria
Collina, Simona
dc.subject.por.fl_str_mv Leishmaniosis
Drug identification
Eremurus persicus
Plant extract
(R)-aloesaponol III-8 methyl ether
topic Leishmaniosis
Drug identification
Eremurus persicus
Plant extract
(R)-aloesaponol III-8 methyl ether
description Leishmaniosis is a neglected tropical disease which affects several millions of people worldwide. The current drug therapies are expensive and often lack efficacy, mainly due to the development of parasite resistance. Hence, there is an urgent need for new drugs effective against Leishmania infections. As a part of our ongoing study on the phytochemical characterization and biological investigation of plants used in the traditional medicine of western and central Asia, in the present study, we focused on Eremurus persicus root extract in order to evaluate its potential in the treatment of leishmaniosis. As a result of our study, aloesaponol III 8-methyl ether (ASME) was isolated for the first time from Eremurus persicus root extract, its chemical structure elucidated by means of IR and NMR experiments and the (R) configuration assigned by optical activity measurements: chiroptical aspects were investigated with vibrational circular dichroism (VCD) and electronic circular dichroism (ECD) spectroscopies and DFT (density functional theory) quantum mechanical calculations. Concerning biological investigations, our results clearly proved that (R)-ASME inhibits Leishmania infantum promastigotes viability (IC50 73 µg/mL), inducing morphological alterations and mitochondrial potential deregulation. Moreover, it is not toxic on macrophages at the concentration tested, thus representing a promising molecule against Leishmania infections.
publishDate 2017
dc.date.none.fl_str_mv 2017
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10316/38794
http://hdl.handle.net/10316/38794
https://doi.org/10.3390/molecules22040519
https://doi.org/10.3390/molecules22040519
url http://hdl.handle.net/10316/38794
https://doi.org/10.3390/molecules22040519
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 1420-3049
http://www.mdpi.com/1420-3049/22/4/519
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.publisher.none.fl_str_mv MDPI
publisher.none.fl_str_mv MDPI
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799133752156225536